Eli Lilly Company News

Even After Shedding Some Weight, Eli Lilly and Company Isn't Prime For Upgrade (NYSE:LLY) - Seeking Alpha

Even After Shedding Some Weight, Eli Lilly and Company Isn't Prime For Upgrade (NYSE:LLY) Seeking Alpha

Eli Lilly & Co (NYSE:LLY) Presents a Prime Case for Affordable Growth Investing - ChartMill

Eli Lilly & Co (NYSE:LLY) Presents a Prime Case for Affordable Growth Investing ChartMill

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions - Eli Lilly

FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions Eli Lilly

Eli Lilly (NYSE:LLY) Tracks Pricing Shifts in Global Markets In Russell 1000 - Kalkine Media

Eli Lilly (NYSE:LLY) Tracks Pricing Shifts in Global Markets In Russell 1000 Kalkine Media

Eli Lilly's Weight Loss Portfolio: Zepbound and Retatrutide Strategy - News and Statistics - IndexBox

Eli Lilly's Weight Loss Portfolio: Zepbound and Retatrutide Strategy - News and Statistics IndexBox

Eli Lilly and the ‘societal obligation’ of GLP-1s - statnews.com

Eli Lilly and the ‘societal obligation’ of GLP-1s statnews.com

Eli Lilly and Company (LLY) Gets Downgraded to Reduce From Hold by HSBC – Here’s Why - Yahoo Finance

Eli Lilly and Company (LLY) Gets Downgraded to Reduce From Hold by HSBC – Here’s Why Yahoo Finance

Steadtrust LLC Acquires $1.3M Stake in Eli Lilly - National Today

Steadtrust LLC Acquires $1.3M Stake in Eli Lilly National Today

After Receiving the Green Light for Its Weight Loss Medication, Is Eli Lilly Stock Set for Rapid Growth? - Bitget

After Receiving the Green Light for Its Weight Loss Medication, Is Eli Lilly Stock Set for Rapid Growth? Bitget

Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance - Eli Lilly

Lilly reports third-quarter 2025 financial results, highlights R&D pipeline momentum and raises 2025 guidance Eli Lilly

BIP Wealth LLC Boosts Eli Lilly Stake by 161% - National Today

BIP Wealth LLC Boosts Eli Lilly Stake by 161% National Today

Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility - Eli Lilly

Lilly selects Pennsylvania as home for its newest injectable medicine and device manufacturing facility Eli Lilly

Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance - Eli Lilly

Lilly reports fourth-quarter 2025 financial results and provides 2026 guidance Eli Lilly

Statement: America’s leading role in biopharmaceutical innovation - Eli Lilly

Statement: America’s leading role in biopharmaceutical innovation Eli Lilly

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI - Eli Lilly

NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery In the Age of AI Eli Lilly

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans - Eli Lilly

Lilly and U.S. government agree to expand access to obesity medicines to millions of Americans Eli Lilly

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - Eli Lilly

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen Eli Lilly

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet - Eli Lilly

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet Eli Lilly

Lilly to acquire Orna Therapeutics to advance cell therapies - Eli Lilly

Lilly to acquire Orna Therapeutics to advance cell therapies Eli Lilly

An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 - Eli Lilly

An open letter from Eli Lilly and Company warning of potential patient safety risks associated with tirzepatide compounded with vitamin B12 Eli Lilly

Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama - Eli Lilly

Lilly to build $6 billion facility to manufacture active pharmaceutical ingredients in Alabama Eli Lilly

How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward - statnews.com

How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward statnews.com

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial - Eli Lilly

Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial Eli Lilly

Jackson Square Capital LLC Boosts Eli Lilly and Company Holdings - National Today

Jackson Square Capital LLC Boosts Eli Lilly and Company Holdings National Today

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market - CNBC

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market CNBC

Eli Lilly Price Target Raised to $880 by Rothschild & Co Redburn - National Today

Eli Lilly Price Target Raised to $880 by Rothschild & Co Redburn National Today

Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients - Eli Lilly

Lilly Employer Connect platform launches with over fifteen independent program administrators offering tailored obesity coverage options to expand access to patients Eli Lilly

Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide - Eli Lilly

Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide Eli Lilly